Shopping Cart
Your Cart is Empty
Quantity:
Subtotal
Taxes
Shipping
Total
A CONVERGENCE OF
A CONVERGENCE OF
PUBLIC HEALTH AND INDIVIDUAL RIGHTS
PUBLIC HEALTH AND INDIVIDUAL RIGHTS
MISSION STATEMENT
MISSION STATEMENT
The Chronic Illness Advocacy & Awareness Group, Inc. (CIAAG) is a national non-profit organization focused on the public, private-partnership initiatives within the healthcare sector. The healthcare system is changing rapidly in response to societal and political pressures. The United States has invested billions of dollars into the restructuring of the healthcare system with a large investment into public, private-partnerships to help create and implement strategies that will help solve the nation's most complex public health issues and concerns. As the nation moves forward with new innovative treatments and technologies, we must ensure patient rights and civil liberties are preserved.
CIAAG acts as a liaison between the public, lawmakers, and other stakeholders to facilitate productive discussions and provide recommendations to address the knowledge gaps and inconsistencies within the public, private-partnerships that are influencing access to care and healthcare as a whole in America.
We consult with the public and private sector, providing both professional expertise and lived experience regarding the issues presented by the use of public, private-partnerships to develop solutions to complex societal problems that arose via the use of pragmatic trials and the biopsychosocial approach to managing population health.
Under Construction
Under Construction
OUR IMPACT
OUR IMPACT
THE LEADERS OF A NEW INDUSTRY
THE LEADERS OF A NEW INDUSTRY
Through identification and recognition of the current issues surrounding the healthcare landscape with the implementation of public, private-partnerships, CIAAG has identified and leading an entire new industry built on the need for oversight, transparency and acknowledgement that all citizens are stakeholders and therefore, require representation.
INTERNATIONAL CHANGE-MAKER
INTERNATIONAL CHANGE-MAKER
CIAAG affected positive societal change by providing valuable insight via their participation as a subject matter expert in group meetings with the UNODC regarding the policy decisions being made at the global level and how they effect the individuals in the communities that we serve.
GLOBAL RECOGNITION
GLOBAL RECOGNITION
A global presence consisting of 29 coalition partners
representing 8,224,066 individuals and 70,000 physicians.
ENGAGEMENT THROUGH EDUCATION
ENGAGEMENT THROUGH EDUCATION
Educational initiatives and events that focus on teaching the strategy that accompanies one’s approach to advocacy and the building blocks of how to approach advocacy through our #CIAAGAdvocacy Chats. These monthly chats have encouraged and increased community engagement and participant confidence; working to amplify our collective voice and increasing awareness amongst the general population.
NATIONAL POLICY ANNOUNCEMENT
NATIONAL POLICY ANNOUNCEMENT
Upon conducting meetings wtih congressional and senatorial offices we presented our research (Violation of A Nation). In response, the FDA provided a safety announcement to the medical community advising against the forced tapering of patients who use opioid pain medications for the treatment of pain/illness.
SIGN UP FOR
SIGN UP FOR
CIAAG's 1st ANNUAL
PUBLIC - HEALTH POLICY ACTIVISM
CIAAG's 1st ANNUAL
PUBLIC - HEALTH POLICY ACTIVISM
TRAINING SERIES
TRAINING SERIES
Training Information
Training Information
Sign up for CIAAG's 1st Public Health Policy Activism series.
Open enrollment has begun for January 2023.
Registration is yearly; only those who are pre-registered will be allowed to attend.
Upon successful completion of the series, each participant will receive a copy of CIAAG's exclusive guidebook.
Fill out the form to the left and click the "sign up here" button to reserve your spot.
Training Series Sign-Up Form
Training Series Sign-Up Form
FOCUS AREAS
FOCUS AREAS
CIAAG EXCLUSIVE REPORTS
CIAAG EXCLUSIVE REPORTS
PUBLIC, PRIVATE - PARTNERSHIPS
ETHICAL GUIDANCE & RECOMMENDATIONS
PUBLIC, PRIVATE - PARTNERSHIPS
ETHICAL GUIDANCE & RECOMMENDATIONS
ANALYSIS OF 2022 CDC OPIOID
PRESCRIBING GUIDELINES
ANALYSIS OF 2022 CDC OPIOID
PRESCRIBING GUIDELINES
VIOLATION OF A NATION
VIOLATION OF A NATION
A CRISIS EXPLOITED
A CRISIS EXPLOITED
SERVICES
SERVICES
PROFESSIONAL SERVICES
PROFESSIONAL SERVICES
- Consulting Services
- Speaking Engagements
- Media Interviews and Appearances
- Develop Policy Whitepapers/Research
- Public Health Policy Analysis
- Monitor and track the impact of public health policy
SUBJECT MATTER EXPERT
SUBJECT MATTER EXPERT
- Public health policy
- Commercial liability insurance
- National and international drug policy
- Enterprise Risk Management
- Strategic planning
- Public-Private Partnerships
COMMUNITY SERVICES
COMMUNITY SERVICES
- Public health policy activism
- Educational materials and webinars
- Exclusive research repository
- Mentorship and training services
- Facilitate communication between patients and other stakeholders
SUCCESSFUL ADVOCACY EFFORTS
SUCCESSFUL ADVOCACY EFFORTS
CIAAG participated in the creation of the UNODC Digital Road Map to
Promote Sustainable Drug Control Public - Private Partnerships which included a number of our recommendations for oversight, transparency and accountability.
CIAAG participated in the creation of the UNODC Digital Road Map to
Promote Sustainable Drug Control Public - Private Partnerships which included a number of our recommendations for oversight, transparency and accountability.
CIAAG 's Executive Director, Lauren Deluca, was 1 of 17 experts selected to particpate on the development of the 1st ever UNODC, "Digital Roadmap," outlining key recommendations for countries to consider when pursuing the use of public-private partnerships (P3's) in relation to national and international drug policy.
The UNODC's publication included a number of recommendations from CIAAG, including but not limited to:
- The need for strong oversight of the public-private partnerships.
- Outlining clear goals and the monitoring of outcomes.
- Regulating the scientific evidence used to create evidence based practices.
This is the first document of its kind providing guidance to countries across the world on best-practices surrounding the public-private partnership initiatives.
We are incredibly proud to have served on this international committee and being able to use our voice to ensure policy guidance includes strong protections for the civil and human liberties of all citizens, in all nations.
CIAAG Successfully Advocated for the
FDA Announcement Against Forced Tapering
CIAAG Successfully Advocated for the
FDA Announcement Against Forced Tapering
CIAAG presented their exclusive report, Violation of a Nation to 9 congressional and senatorial offices in April 2019. Our team requested a federal announcement be issued against the practice against involuntary discontinuation from opioid analgesic medications. CIAAG founder Lauren Deluca, stated, "There is substantial evidence of the harms of this practice at this juncture. it would be irresponsible not to. "
As a result of this request, the FDA issued an annoucement against the practice of involuntary discontinuation from opioid analgesic medications and the misapplication of federal guidance documents.
Link to Announcement
Link to Announcement
